Additionally, we observed poor survival outcome of CRC for patients with high expression of TDRKH-AS1 (Figure 2D) These results implied that the high expression of TDRKH-AS1 in CRC patients' tumor tissues is an important event, and it could be a prognostic diagnostic indicator in clinical settings. Here, TDRKH is linked to neoplasm.